Drug Trial Radar · NCT01919801
Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Last checked: Nov 20, 2026Latest source record: Jun 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
118
Actual
Start
Dec 2, 2013
Primary completion
Aug 22, 2015
Study completion Aug 22, 2015
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- PPD Development, LP
- First posted
- Aug 9, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being conducted to compare the safety and efficacy of icatibant with placebo in the treatment for Angiotensin-Converting Enzyme Inhibitor (ACE-I)-Induced Angioedema in Adults.
Conditions
- Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Interventions
IcatibantDrug
Single dose of 30 mg icatibant administered within 12 hours of the onset of an acute attack of ACE-I-induced angioedema
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Meeting Discharge Criteria (TMDC)Time frame: Day 0 up to Day 5
- Number of Participants With Treatment-emergent Adverse Events (TEAE) and Treatment-emergent Serious Adverse Events (TESAEs)Time frame: From start of study drug administration (Day 0) up to follow-up (Day 5)
- Number of Participants With Treatment Emergent Injection Site ReactionTime frame: Day 0 to Day 5
- Number of Participants With Clinically Significant Changes in Laboratory Evaluation, Vital Signs, Electrocardiogram (ECG) and Physical ExaminationTime frame: Day 0 to Day 5
Locations
55 sites in 4 countries. Site status is shown where the registry gives one.
University of California San Diego Medical Center
La Jolla, California
University of California San Diego
La Jolla, California
Washington Hospital Center
Washington D.C., District of Columbia
UF Health Shands Hospital
Gainesville, Florida
Orlando Health
Orlando, Florida
Tampa General Hospital
Tampa, Florida
Federal Health Care Center
Chicago, Illinois
Cook County Hospital
Chicago, Illinois
University of Kansas Cancer Center
Kansas City, Kansas
Ochsner Medical Center
New Orleans, Louisiana
University of Maryland School of Medicine
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Brigham and Womens Hospital
Boston, Massachusetts
Baystate Medical Center
Springfield, Massachusetts
Detroit Receiving Hospital and University Health Center
Detroit, Michigan
Sinai Grace Hospital
Detroit, Michigan
Henry Ford Health System
Detroit, Michigan
William Beaumont Hospital
Royal Oak, Michigan
William Beaumont Hospital
Troy, Michigan
Hennepin County Medical Center
Minneapolis, Minnesota
Barnes Jewish Hospital
St Louis, Missouri
Washington University
St Louis, Missouri
Inspira Health Network
Vineland, New Jersey
University of New Mexico
Albuquerque, New Mexico
Kings County Hospital Center
Brooklyn, New York
SUNY Downstate Medical Center
Brooklyn, New York
Weill Medical College of Cornell University
New York, New York
East Carolina University
Greenville, North Carolina
University of Cincinnati
Cincinnati, Ohio
Cleveland Clinic Foundation
Cleveland, Ohio
Ohio State University Hospital - East
Gahanna, Ohio
Summit Health
Chambersburg, Pennsylvania
Hahnemann University Hospital
Philadelphia, Pennsylvania
Temple University Hospital
Philadelphia, Pennsylvania
Albert Einstein Medical Center
Philadelphia, Pennsylvania
Allegheny General Hospital
Pittsburgh, Pennsylvania
Rhode Island Hospital
Providence, Rhode Island
University of South Carolina School of Medicine
Columbia, South Carolina
Baylor University Medical Center
Dallas, Texas
John Peter Smith Hospital
Fort Worth, Texas
Showing 40 of 55 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.